Switzerland· 67893002

Doptelet

A avatrombopag product containing avatrombopagum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC B02BX08

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedDopteletATCB02BX08REGISTER NO.67893002PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Avatrombopag is registered in 15 of 19 countries.

Countries holding a registration under ATC B02BX08 (avatrombopag), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Avatrombopag · ATC B02BX08

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of avatrombopag costs, country by country.

Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.

  • Switzerland: $82.67 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Avatrombopag · price per daily dose (20 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$82.67
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
avatrombopagum
Manufacturer
—
Country
Switzerland (CH)
ATC code
B02BX08
ATC class
Avatrombopag
Defined daily dose
20 mg, O
Swissmedic category
A
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680678930026
    Blist 15 Stk
    CHF 1028.45

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

59 interactions on record for avatrombopag.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Avatrombopag · interactions on record

59 records

  • 14 severe
  • 45 moderate

Most severe, free to view

  • FluconazoleJ02AC01severe
  • RifampicinJ04AB02severe
  • RifapentineJ04AB05severe
  • ImatinibL01EA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Avatrombopag in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All avatrombopag products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Doptelet
  • Liechtenstein · Doptelet
  • Norway · Doptelet

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/079fec05-15eb-4c1a-ac80-c86467b3fb3b
GET /v1/drugs/079fec05-15eb-4c1a-ac80-c86467b3fb3b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "avatrombopagum 20 mg",
  "valid_from": "2022-01-01",
  "limitations": "[{\"description\":\"Zur Behandlung einer schweren Thrombozytopenie bei erwachsenen Patienten mit chronischer Lebererkrankung (CLD), bei denen ein invasiver Eingriff geplant ist und die zu Beginn der Behandlung eine Thrombozytenzahl von mindestens 20 * 10<sup>9</sup>/L aufweisen.<br>\\nZur Behandlung von erwachsenen Patienten mit chronischer Immunthrombozytopenie (immunthrombozytopenischer Purpura, ITP) definiert als eine mindestens 12 Monate ab Diagnose dauernde ITP. Die Patienten müssen auf mindestens eine vorherige Behandlung (zum Beispiel Kortikosteroide, Azathioprin oder Immunglobuline) unzureichend angesprochen haben. DOPTELET darf nicht in Kombination mit REVOLADE oder NPLATE verabreicht werden.<br>\\n<br>\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2022-01-01\",\"validTo\":null}]",
  "galenic_form": "Filmtabl 20 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2022-01-01",
  "self_retention_pct": 10
}

See everything about avatrombopag.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.